Poordad F, Castro RE, Asatryan A, Aguilar H, et al. Long-Term Safety and Efficacy Results in Hepatitis C Virus Genotype 1-Infected Patients Receiving Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir +/- Ribavirin in the TOPAZ-I and TOPAZ-II Trials. J Viral Hepat 2020 Jan 18. doi: 10.1111/jvh.13261.
PMID: 31954087